https://www.selleckchem.com/JAK.html
arlier immunosuppressive treatment before surgery is needed. To compare the Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) against the Ankylosing Spondylitis Disease Activity Score (ASDAS) for measuring and categorizing disease activity using data from the EMBARK trial (ClinicalTrials.gov NCT01258738), a randomized controlled trial of etanercept (ETN) for axial spondyloarthritis (axSpA). Patients with early active axSpA received ETN 50 mg once weekly (n = 106) or placebo (PBO; n = 109) for 12 weeks in a double-blind manner; they t
Like
Comment
Share
